SerenaGroup
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, SerenaGroup sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
SerenaGroup: 10 sponsored US clinical trials, 2 recruiting.
SerenaGroup sponsors 10 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 6 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy Adult, with 2 trials.
Top-decile sponsor footprint
SerenaGroup ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
Assessment of Skin Irritation and Sensitization of SILURCLOUD Fibrous Collagen Matrix
NCT07473661
Skin Prick Test to Evaluate Immunogenic Response of SILURCLOUD™ Fibrous Collagen Matrix in Healthy Volunteers
NCT07473674
Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers
NCT03154619
A Prospective Clinical Study Evaluating the Harvesting of Micografts
NCT05076578
A Comparison Between Two Post-operative Dressings
NCT04888624
Randomized Double-Blind Controlled Clinical Trial
NCT04320628
The Effectiveness of a Mechanical Debridement Instrument in Reducing Bioburden in Chronic Wounds
NCT04342767
Effect of Meso Wound Matrix in the Treatment of DFUs
NCT04182451
Evaluating Blast-X® in Combination With Negative Pressure Wound Therapy
NCT04265170
Clinical Trial to Evaluate Blister Graft Utilizing a Novel Harvesting Device for Treatment of Venous Leg Ulcers
NCT02148302
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
What is open in the SerenaGroup pipeline
2 recruiting of 10 indexed (20% open); 6 completed (60%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Healthy Adult (2 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
SerenaGroup: open-pipeline peers nationwide
Peers matched on 10 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
SerenaGroup sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
Related
What to do with this SerenaGroup page
10 registered trials is a research-attention snapshot, not an endorsement of SerenaGroup or any single study.
- 2 of SerenaGroup's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy Adult is the condition SerenaGroup studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy Adult trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
SerenaGroup pipeline card: 10 registered trials from official public datasets.Report a data error.